AlphaCrest Capital Management’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,842
Closed -$285K 1357
2021
Q4
$285K Buy
+9,842
New +$285K 0.01% 1268